BasoFunction HRT Amaranth
Test Code: 501390
Cpt Code:86352 (x1)
Clinical UtilityThe BasoFunction test may be useful with patients who have a suggestive history of adverse reactions to the indicated allergen and for whom skin testing is not appropriate or available.
ProcedureCell Setup: Peripheral blood leukocytes are enriched from heparinized whole blood and stimulated with fMLP Basophil Activation Test, allergen (BasoFunction Test) or buffer alone. Following a brief culture the supernatant containing secreted histamine is separated from the cells. Histamine Test: A validated histamine ELISA quantifies histamine that was secreted by any stimulated control. Viracor-IBT Laboratories determined the performance characteristics of this test. This test has not been cleared or approved for diagnostic use by the U.S. Food and Drug Administration.
Assay RangeThe reference range varies for each allergen
Causes For RejectionHemolyzed, frozen or refrigerated blood is not acceptable and will be rejected for testing. Do Not use Lithium Heparin tubes
Turnaround TimeSetup Schedule: Basophil Activation M-F, ELISA portion: Mon, Tues, Thurs. TAT: 3-4 Business days from receipt of specimen
ShippingShip OVERNIGHT. Samples are received Monday thru Friday ONLY. Call lab with tracking number. Specimen MUST BE received within 48 hours of draw.
48 hours ambient
Specimens are approved for testing in New York only when indicated in the Specimen Type and Specimen Handling field above.
The CPT codes provided are based on Viracor-IBT's interpretation of the American Medical Association's Current Procedural Terminology (CPT) codes and are provided for general informational purposes only. CPT coding is the sole responsibility of the billing party. Questions regarding coding should be addressed to your local Medicare carrier. Viracor-IBT assumes no responsibility for billing errors due to reliance on the CPT codes illustrated in this material.
Gruchalla, R S. J Allergy Clin Immunol 2001, 108 (4):475-488.
Winther, L et al. Allergy 1999, 54: 436-445.
Zia, P. K. et al. Clinical Chemistry 1998, 44: 2063-2065.
Sainte-Laudy, J et al. Inflammation Research 1998, 47: 401-8.